Recent publications have provided indications and dosages of neuromodulators and fillers.^[@R1]^ To achieve consistent results utilizing facial injectables, practitioners must understand the pertinent anatomy of the forehead, temple, cheek, nose, and perioral areas. Key anatomy will be highlighted for safe and efficacious injections of neuromodulators and fillers.

FOREHEAD
========

To treat forehead rhytids, neuromodulator injections into the frontalis should be at least 2 cm above the orbital rim to prevent brow ptosis. The corrugator supercilii and procerus muscles are the 2 main brow depressors responsible for glabellar rhytids. When injecting these muscles with neuromodulators, their inferior bony origin and superior dermal insertions must be kept in mind. (**See** **video, Supplemental Digital Content [1](#V1){ref-type="fig"}**, which teaches the proper techniques to safely administer injectables into the forehead and temporal regions by demonstrating on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A310>.)

![Anatomical approach to injectables in the forehead and temporal regions teaches the proper techniques to safely administer injectables into the forehead and temporal regions by demonstrating the techniques on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A310>).](gox-4-e1166-g001){#V1}

Likewise, fine rhytids in the glabellar region can be treated with intradermal filler injections. In multiple reviews, the glabella was the most common filler injection site leading to visual loss.^[@R2],[@R3]^

TEMPORAL REGION
===============

The frontal branch of the temporal artery traverses the temporal hollow within the temporoparietal fascia. (**See** **video, Supplemental Digital Content [2](#V2){ref-type="fig"}**, which teaches the proper techniques to safely administer injectables into the cheeks by demonstrating on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A311>) Cannulation of this branch can lead to ischemia and blindness via anastomoses with the supraorbital and supratrochlear arteries. Therefore, inject into the superficial subcutaneous plane taking care to stay above the temporoparietal fascia.

![Anatomical approach to injectables in the cheeks teaches the proper techniques to safely administer injectables into the cheeks by demonstrating on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A311>.](gox-4-e1166-g002){#V2}

Neuromodulator injections into the lateral orbicularis oculi treat periorbital rhytids. Along the lateral orbital rim, injections begin below the tail of the brow, proceeding inferiorly to the vertical plane of the lateral canthus. Injections should be subdermal because deeper ones can paralyze the zygomaticus major, weakening the ipsilateral smile.

CHEEK
=====

Aesthetic facial contours are formed through sustained fullness within the facial fat compartments, most importantly the deep and high (superficial) malar compartments.^[@R4]^ Clinically, the infraorbital foramen lies slightly less than a fingerbreadth below the infraorbital rim in the vertical plane immediately lateral to the medial limbus. When injecting a filler into the malar fat compartments, stay lateral to the infraorbital foramen. Injections can be superficial or deep depending on the location of volume loss.

In the inferior two thirds of the nasolabial fold, filler injections should be in the superficial subcutaneous tissue or deep dermal plane so as to avoid the facial artery. Because the facial artery becomes superficial superiorly, injections in the superior third of the nasolabial fold should be in the deep dermal or in the preperiosteal plane.

NOSE
====

The nasal vessels are superficial. To avoid vessel injury or compression, filler injections into the tip and dorsum should be in the preperiosteal and preperichondrial layers. Because the lateral nasal artery runs in the subdermal plexus 2 to 3 mm superior to the alar groove, injections into the sidewall should be above this landmark.^[@R5]^ (**See video, Supplemental Digital Content 3**, which teaches the proper techniques to safely administer injectables into the nose and perioral regions by demonstrating on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A312>.) Proceed with extreme caution in patients who have had multiple nasal surgeries as the remaining blood supply to the nose is unpredictable.

![Anatomical approach to injectables in the nose and lips teaches the proper techniques to safely administer injectables into the nose and perioral regions by demonstrating on a cadaver. This video is available in the "related videos" section of the full-text article on PRSGlobalOpen.com or available at <http://links.lww.com/PRSGO/A312>.](gox-4-e1166-g003){#V3}

PERIORAL
========

Upper and lower lip filler injections should be less than 3 mm deep and within vermillion-cutaneous border or the dry vermillion. Commissure injections proceed in the superficial subcutaneous plane within a thumb breadth of the angle of the mouth. Both techniques avoid injury to the labial and facial arteries, respectively.

Various locations of injections of neuromodulators exist in the perioral area.^[@R6]^ It is important to understand the relationship between the depressor anguli oris and the depressor labii inferioris. Neuromodulator injections of the depressor anguli oris should be superficial and immediately medial to the mandibular ligament to avoid inadvertent injection of the depressor labii inferioris.

CONCLUSIONS
===========

A detailed knowledge of facial anatomy allows safe and efficacious injections of neuromodulators and fillers.
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